Our Cell Processing Facility (CPF) is a Good Manufacturing Practice, or GMP, bioprocessing manufacturing facility that supports the reproducible production of human hematopoietic or immune-competent ...
A review in the Chinese Journal of Natural Medicines examines how natural products can improve the in vivo fate of mesenchymal stem cells (MSCs), with potential benefits for cell homing, survival, ...
Parexel provides clinical development capabilities and consulting services—including services focused on regulatory strategy and development planning, “good practice” compliance, regulatory ...
Raman spectroscopy will likely become a key technology for monitoring upstream and downstream processing as well as manufacturing of cell and gene therapies (CGT) in the coming years. New applications ...
There are many different types of cancer therapies in the clinical space, and immunotherapies are a novel one. A subsection of immunotherapies is cell therapy, modifying immune cells to have better ...
NEW YORK, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Cell BioEngines, Inc., a clinical-stage biotechnology company focused on delivering novel, innovative stem cell and immune cell therapies to address blood ...
As of September 26, 2024, 33 CD19 CAR T-naïve patients with LBCL (median age, 66 years; median number of previous therapies, 3) received allogeneic CAR T cells. CAR T-cell expansion was observed ...
FDA has sent a warning letter to a company that makes stem cell and platelet-rich plasma products -- for pets. The agency told Texas-based Safari Stem Cell that statements on the company's website and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results